Producción científica
La investigación de Navarrabiomed en cifras
Producción científica
La producción científica registrada en la We3b of Science para el año 2024 incluye un total de 194 publicaciones, de las cuales 131 corresponden a artículos, revisiones o letters publicadas en revistas indexadas en JCR (Citables_JCR). Estas publicaciones Citables_JCR presentan un factor de impacto promedio de 6,5. Además, un 50% de ellas están lideradas por científicos de Navarrabiomed, un 77% se encuentran en revistas de cuartil 1 y un 95% en revistas de cuartil 1 o 2. Un 67% están incluídas en alguna de las tipologías de acceso abierto y un 64% son colaboraciones internacionales.
Actividad investigadora
Publicaciones destacadas
2025 I Cardiovascular Research
The loss of microRNA-26b promotes aortic calcification through the regulation of cell-specific target genes
2025 I European Journal of Preventive Cardiology
External validation of cardiovascular risk scores in patients with Type 2 diabetes using the Spanish population-based CARDIANA cohort
2025 I Diabetes Care
Effect of Diactive-1 mHealth-Supported Progressive Resistance Training on Insulin Requirements, Glycemic Stability, and Muscular Strength in Children and Adolescents With Type 1 Diabetes: A Parallel-Group Randomized Controlled Trial Available to Purchase
2025 I Nucleic Acids Research
ExcludonFinder: mapping transcriptional overlaps between neighboring genes
2025 | Communications Biology
Unusual traits shape the architecture of the Ig ancestor molecule
2024 | Nature Microbiology
Bacteriophages avoid autoimmunity from cognate immune systems as an intrinsic part of their life cycles
2024 | Brain Pathology
Neuropathological stage-dependent proteome mapping of the olfactory tract in Alzheimer's disease: From early olfactory-related omics signatures to computational repurposing of drug candidates
2023 | Neurology
Association of Blood-Based DNA Methylation Markers With Late-Onset Alzheimer Disease: A Potential Diagnostic Approach
2023 I Nature Metabolism
Metabolic rewiring induced by ranolazine improves melanoma responses to targeted therapy and immunotherapy
2023 I Brain, Behavior, and Immunity
Profiling TREM2 expression in amyotrophic lateral sclerosis